ENB-29571-14712
3 vaccinations
2 coded responses
8 check-ins
2 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 559 / MN
- Registered
- 2022-10-07
- Relationship
- Child or adolescent in my care
- Guardian
- 374-31735-92037
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-13
Dose 1 — Pfizer-BioNTech
-
2022-08-03
Dose 2 — Pfizer-BioNTech
-
2022-09-28
Dose 3 — Pfizer-BioNTech
-
2022-10-07
Registered in v-safe
- 2022-10-07
- 2022-10-12
- 2022-10-19
- 2022-10-26
-
2022-11-02
Survey response — day 35, dose 3, under 3MedDRA: Nasopharyngitis, Rhinorrhoea, Sneezing — Feeling: FairFree text: He has a common cold. Sniffles and sneezes.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-09
Survey response — day 42, dose 3, under 3MedDRA: Influenza — Feeling: Fair · Be unable to work or attend schoolFree text: Influenza virusMedDRA releases: 2024-11 · check-in free text available
- 2022-12-29
- 2023-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-13 | Pfizer-BioNTech | No |
| 2 | 2022-08-03 | Pfizer-BioNTech | No |
| 3 | 2022-09-28 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — day 35, dose 3, under 3
Symptoms: He has a common cold. Sniffles and sneezes.
Release 12 (Under 3) — day 42, dose 3, under 3
Symptoms: Influenza virus
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Influenza | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release